Telcon Inc (200230 KQ) stock market data APIs
₩1287.1297
40.43(3.1%)
as of September 16, 2025
Try our APIs with
free plan!
Telcon Inc Financial Data Overview
Price chart is built with
Anychart
TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.
Prev. Close
1287.1297
Open
1327.5619
High
1327.5619
Low
1270.4128
52 wk Range
769.6615-4405
Market Cap
57 184 M
Shares Outstanding
44 570 K
Revenue
41 016 M
EPS
-40.3407
Beta
1.074
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Telcon Inc data using free add-ons & libraries
Get Telcon Inc Fundamental Data
Telcon Inc Fundamental data includes:
- Net Revenue: 41 016 M
- EBITDA: 4 561 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-30
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Telcon Inc News
New
Emmaus Life Sciences Announces the Sale of its Telcon RF Pharmaceutical Inc. Shares
TORRANCE, Calif., Oct. 14, 2020 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, announced today that it has sold all remaining common shares of South...
Emmaus Life Sciences Announces the Sale of its Telcon RF Pharmaceutical Inc. Shares
TORRANCE, Calif., Oct. 14, 2020 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTC: EMMA), a leader in sickle cell disease treatment, announced today that it has sold all remaining common shares of South...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
